From: Vitamin D status and its influence on outcomes following major burn injury and critical illness
Target cells/tissues | Effects of vitamin D | Reference |
---|---|---|
Adipocytes | • Inhibits intracellular fat accumulation • Enhances basal lipolysis without cell toxicity • Upregulation of β-oxidation-related genes, lipolytic enzymes, and vitamin D-responsive genes • Increased levels of nicotinamide adenine dinucleotide and sirtulin 1 expression | [105] |
Cardiomyocytes | • Inhibition of cell proliferation without apoptosis • Downregulation of expression of genes associated with cell cycle regulation • Promotes cardiomyotube formation • Induces cardiac differentiation | |
Hepatocytes | • Protects against insulin resistance • Downregulates fibrogenic TGF-β signaling • Anti-inflammatory effects by inhibiting monocyte activation and TNF-α and IL-1 expression | |
Myocytes | • Modulation of calcium homeostasis and influx • Induces cellular proliferation and differentiation • Protects against insulin resistance • Stimulation of arachidonic acid mobilization | |
Nephrocytes | • Upregulation of cellular metabolic activity, IL-6, and reactive oxygen species • Restoration of transepithelial barrier function | [113] |
Neurons | • Neuroactive steroid modulating spontaneous regular firing, actin potential duration, and intrinsic excitability • Enhances sensitivity to neurotransmitters and neurotransmitter receptors • Upregulation of neuronal growth factors, neurotrophin 3, and glial cell line-derived neurotrophic factor | |
T cells | • Inhibits Th1/Th17 chemokine/cytokine secretion (CXCL-10, IFN-γ, TNF-α, and IL-17) • Enhances Th2 cytokine release (IL-4 and IL-5) | |
B cells | • Downregulates the proliferation of memory B cells • Inhibits plasma cell differentiation • Reduces Ig production | [117] |
Antigen-presenting cells | • Inhibits the expression of class II MHC molecules (HLA-DR) • Inhibition of co-stimulating molecule expression (CD80, CD83, and CD86) • Augments chemotaxis and phagocytosis of monocytes • Downregulates the maturation of dendritic cells • Induces tolerogenic dendritic cells capable of inducing Treg cells • Inhibits IL-12 p70 release • Decreases macrophage-stimulated pro-inflammatory cytokine production (IL-1, IL-1β, IL-6, IL-8, MCP-1, and RANTES) | |
NK cells | • Inhibition of NK cell development and differentiation • Reduced INF-γ and cytotoxicity | [122] |